Media Summary: Jane King interviews Solomon Moshkevich, General Manager Oncology, When a patient with a personal or family history of chronic kidney disease (CKD) has a negative Katie was concerned about her risk for cancer after her mother died of breast cancer at a young age. She had heard of

My Natera Com They Warned Me About This Genetic Predisposition Information - Detailed Analysis & Overview

Jane King interviews Solomon Moshkevich, General Manager Oncology, When a patient with a personal or family history of chronic kidney disease (CKD) has a negative Katie was concerned about her risk for cancer after her mother died of breast cancer at a young age. She had heard of

Photo Gallery

Natera: Personalized Genetic Testing and Diagnostics
Negative Genetics Results in Kidney Disease: Part 1 - The Why | Natera Academy | Meg Hager
Horizon Carrier Screening Overview
Patient Perspective: Discovering Genetic Cancer Risk
Natera Oncology
Natera CEO: We’re using DNA tech to change disease management
Natera CEO Steve Chapman on kidney genetics
11 Weeks Pregnant: Should You Take a NIPT Genetic Test? | Miss Toni
Panorama NIPT Overview
Episode #84: Why You Should Be Cautious Of Most Consumer Genetic Testing
Natera's Panorama & Horizon Test
Natera: Revolutionizing healthcare with generation cell free DNA testing
Sponsored
View Detailed Profile
Natera: Personalized Genetic Testing and Diagnostics

Natera: Personalized Genetic Testing and Diagnostics

Jane King interviews Solomon Moshkevich, General Manager Oncology,

Negative Genetics Results in Kidney Disease: Part 1 - The Why | Natera Academy | Meg Hager

Negative Genetics Results in Kidney Disease: Part 1 - The Why | Natera Academy | Meg Hager

When a patient with a personal or family history of chronic kidney disease (CKD) has a negative

Horizon Carrier Screening Overview

Horizon Carrier Screening Overview

Horizon

Patient Perspective: Discovering Genetic Cancer Risk

Patient Perspective: Discovering Genetic Cancer Risk

Katie was concerned about her risk for cancer after her mother died of breast cancer at a young age. She had heard of

Natera Oncology

Natera Oncology

Natera

Sponsored
Natera CEO: We’re using DNA tech to change disease management

Natera CEO: We’re using DNA tech to change disease management

Jim Cramer chats with

Natera CEO Steve Chapman on kidney genetics

Natera CEO Steve Chapman on kidney genetics

Natera

11 Weeks Pregnant: Should You Take a NIPT Genetic Test? | Miss Toni

11 Weeks Pregnant: Should You Take a NIPT Genetic Test? | Miss Toni

I ordered a

Panorama NIPT Overview

Panorama NIPT Overview

Panorama is a blood-based

Episode #84: Why You Should Be Cautious Of Most Consumer Genetic Testing

Episode #84: Why You Should Be Cautious Of Most Consumer Genetic Testing

My

Natera's Panorama & Horizon Test

Natera's Panorama & Horizon Test

Panorama™ is a blood-based

Natera: Revolutionizing healthcare with generation cell free DNA testing

Natera: Revolutionizing healthcare with generation cell free DNA testing

Jane King interviews Steve Chapman, CEO,

Negative Genetics Results in Kidney Disease: Part 2 - What Next? | Natera Academy | Meg Hager

Negative Genetics Results in Kidney Disease: Part 2 - What Next? | Natera Academy | Meg Hager

When a patient with a personal or family history of chronic kidney disease (CKD) has a negative